Literature DB >> 12800262

Hepato-splenic lymphoma: a rare entity mimicking acute hepatitis: a case report.

Federico Perfetto1, Roberto Tarquini, Francesco Mancuso, Simonetta Di Lollo, Silvia Tozzini, Giampiero Bellesi, Giacomo Laffi.   

Abstract

We reported a case of non-Hodgkin's lymphoma where liver involvement was the predominant clinical manifestation. A 27-year old man presented with markedly elevated serum aspartate aminotrasferase, alanine aminotransferase and lactate dehydrogenase, reduced prothrombin activity, thrombocytopenic purpura and hepato-splenomegaly without adenopathy. Viral, toxic, autoimmune and metabolic liver diseases were excluded. Bone marrow biopsy showed an intracapillary infiltration of T-lymphocytes with no evidence of lipid storage disease. Because of a progressive spleen enlargement, splenectomy was performed. Histological examination showed lymphomatous intrasinuses invasion of the spleen. Immunohistochemical investigation revealed the T phenotype of the neoplastic cells: CD45+, CD45RO+, CD3+, CD4-, CD8-, TIA1-. About 50 % of the lymphoid cells expressed CD56 antigen. The diagnosis of hepatosplenic T cell lymphoma was done. The patient was treated with chemotherapy, which induced a complete remission. Eighteen months later, he had a first relapse with increased aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase, thrombocytopenic purpura and blast in the peripheral blood. In spite of autologous bone marrow transplantation, he died twenty months after the diagnosis. Even in the absence of a mass lesion or lymphoadenopathy, hepatosplenic T-cell lymphoma should be considered in the differential diagnosis of a patient whose clinical course is atypical for acute hepatic dysfunction.

Entities:  

Mesh:

Year:  2003        PMID: 12800262      PMCID: PMC4611822          DOI: 10.3748/wjg.v9.i6.1381

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  9 in total

Review 1.  Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.

Authors:  N L Harris; E S Jaffe; J Diebold; G Flandrin; H K Muller-Hermelink; J Vardiman
Journal:  Ann Oncol       Date:  2000       Impact factor: 32.976

2.  Hepatosplenic gammadelta T-cell lymphoma: ultrastructural, immunophenotypic, and functional evidence for cytotoxic T lymphocyte differentiation.

Authors:  K E Salhany; M Feldman; M J Kahn; D Peritt; R D Schretzenmair; D M Wilson; R S DiPaola; A D Glick; J A Kant; P C Nowell; M Kamoun
Journal:  Hum Pathol       Date:  1997-06       Impact factor: 3.466

3.  Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: A study of 38 cases.

Authors:  P Gaulard; P Kanavaros; J P Farcet; F D Rocha; C Haioun; M Divine; F Reyes; E S Zafrani
Journal:  Hum Pathol       Date:  1991-04       Impact factor: 3.466

4.  Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas.

Authors:  W R Macon; N B Levy; P J Kurtin; K E Salhany; M Y Elkhalifa; T T Casey; F E Craig; C L Vnencak-Jones; M L Gulley; J P Park; J B Cousar
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

Review 5.  Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990.

Authors:  E Weidmann
Journal:  Leukemia       Date:  2000-06       Impact factor: 11.528

6.  Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.

Authors:  C B Cooke; L Krenacs; M Stetler-Stevenson; T C Greiner; M Raffeld; D W Kingma; L Abruzzo; C Frantz; M Kaviani; E S Jaffe
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

7.  Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta.

Authors:  J P Farcet; P Gaulard; J P Marolleau; J P Le Couedic; T Henni; M F Gourdin; M Divine; C Haioun; S Zafrani; M Goossens
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

8.  Peripheral T-cell lymphoma presenting as predominant liver disease: a report of three cases.

Authors:  P Gaulard; E S Zafrani; P Mavier; F D Rocha; J P Farcet; M Divine; C Haioun; Y Pinaudeau
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

  9 in total
  5 in total

1.  Hepatic failure and death due to new onset T cell lymphoma.

Authors:  Ekta Gupta; James E Rose; Joel E Straughen; Laura E Lamps; Kevin W Olden
Journal:  J Gastrointest Cancer       Date:  2011-09

Review 2.  TIM-1, a novel allergy and asthma susceptibility gene.

Authors:  Jennifer J McIntire; Dale T Umetsu; Rosemarie H DeKruyff
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

3.  Hepatosplenic alpha/beta T-cell lymphoma masquerading as cirrhosis.

Authors:  Jonah Cohen; Eduardo Hariton; Darshan Kothari; German A Pihan; Simon C Robson
Journal:  J Gastrointest Oncol       Date:  2013-06

4.  The imaging conundrum of hepatic lymphoma revisited.

Authors:  S Rajesh; Kalpana Bansal; Binit Sureka; Yashwant Patidar; Chhagan Bihari; Ankur Arora
Journal:  Insights Imaging       Date:  2015-10-06

5.  Purpura of the face and neck: an atypical clinical presentation revealing a hepatosplenic T cell lymphoma.

Authors:  François Kuonen; Maya Bucher; Laurence de Leval; Maxime Vernez; Michel Gilliet; Curdin Conrad; Laurence Feldmeyer
Journal:  Case Rep Dermatol       Date:  2014-02-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.